Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-29

Clinical Trial Update: Effect of HSV-2 Suppressive Therapy on Sexual Behavior [Phase 4]

View source ↗

Summary

Phase 4 trial investigating the effect of HSV-2 suppressive therapy on sexual behavior in individuals with genital herpes; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HSV-2 suppressive therapy

Snippet

Sponsor: University of Washington | Conditions: Genital Herpes | Phase 4 | Status: TERMINATED | Results posted: 2020-01-29